2016 -
now Board Member, Houston Methodist, Translational Research Institute @ Houston Methodist
2018 -
2020 Vice President Of Product Development @
2015 -
2019 Vice President, Nonclinical Development @ Salarius Pharmaceuticals
2015 -
2018 Vice President, Nonclinical Development @ Beta Cat Pharmaceuticals, now Iterion Therapeutics
2012 -
2015 Vice President @ Texas BioAlliance
2008 -
2012 President and CEO @ Parady Consulting, Inc.
2010 -
2011 VP, Drug Development @ Wildcat Venture Management
2009 -
2011 Associate VP of Nonclinical Development @
2001 -
2007 Senior Director Preclinical Development @
1999 -
2001 Director of Toxicology - San Diego @
1999 -
2000 Director @ Aronex Pharmaceuticals
1997 -
1998 Senior Toxicologist @
1993 -
1997 Staff Toxicologist @
1990 -
1993 Post-doctoral fellow @ Chemical Industry Institute of Toxicology
Jeffrey Larson Education
Washington State University
Ph.D. (Pharmacology/Toxicology)
1986
-
1990
Minot State University
BA (Environmental Science)
1981
-
1986
Jeffrey Larson Skills
GLP
Toxicology
CRO
Clinical Development
IND
Biotechnology
Bioterrorism
Drug Development
Medical Devices
Pharmacology
Immunology
Clinical Trials
Pharmaceutical Industry
Biologics
Biochemistry
Oncology
Cell
Protein Chemistry
Pharmacokinetics
FDA
Cell Culture
Drug Discovery
Regulatory Submissions
R&D
Cancer
In Vitro
In Vivo
Lifesciences
Molecular Biology
Monoclonal Antibodies
Microbiology
Therapeutic Areas
Technology Transfer
Biopharmaceuticals
CRO Management
Clinical Pharmacology
U.S. Food and Drug Administration (FDA)
Good Laboratory Practice (GLP)
Life Sciences
Clinical Toxicology
Virology
Mechanisms
Agents
Marketing Strategy
Gap Analysis
Resistance
Licensing
Mouse
Influenza
Administration
Presentation
Strategic Planning
Planning
Investigator Brochures
Annual Budgets
Phase Iii
Filing
Development Strategy
Clinical Data
SAN
Titles
Project Management
Communication
Manuscript
Vivarium
Protocol
Injury
Toxicity
Pathogens
House
Birth
Trials
Supervision
Rpr
Simulations
Design
Risk Assessment
Drinking Water
Litigation
Business Development
Consulting
Gene Therapy
Characterization
Pla
Phase Ii
Drug Delivery
Immunocytochemistry
Components
Government
Training
NDA
Analytical Skill
Bioassay
Manufacturing
Strategic Insights
Developmental
Project Plans
Dogs
Strategy
Efficacy
Grants
Budgets
Treatment
Profit
Deals
Healthcare
Injectable
Kinetics
Budgeting
Commercialization
Cytotoxicity
Drug Safety
Metabolism
Supply
Evaluations
Lists
Supervisor
Inhalation
Resources
Defense
Maa
CTA
Regulatory Requirements
Subcutaneous
Laboratory
Proof
Acute
Facets
Oversight
Proliferation
Clinical Research
HPLC
Regulatory Filings
Assessment
Funding
Modeling
Jeffrey Larson Summary
Jeffrey Larson, based in Houston, TX, US, is currently a SVP R and D at Tvardi Therapeutics. Jeffrey Larson brings experience from previous roles at Houston Methodist, Iterion Therapeutics, Salarius Pharmaceuticals and Beta Cat Pharmaceuticals, now Iterion Therapeutics. Jeffrey Larson holds a 1986 - 1990 Ph.D. in Pharmacology/Toxicology @ Washington State University. With a robust skill set that includes GLP, Toxicology, CRO, Clinical Development, IND and more. Jeffrey Larson has 2 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.